ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,361Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 1111

$582K Total Retail Price of All Prescriptions

Rank: 159 out of 1111

415 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 415 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 415 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 11,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 617 597 1 4
SIMVASTATIN 611 608 2 5
LEVOTHYROXINE SODIUM 449 395 3 3
POTASSIUM CHLORIDE 391 370 4 9
FUROSEMIDE 310 278 5 6
ATENOLOL 260 250 6 22
DONEPEZIL HCL 243 242 7 25
HYDROCODONE-ACETAMINOPHEN 233 227 S3 8 1
HYDROCHLOROTHIAZIDE 222 215 9 11
TAMSULOSIN HCL 213 210 10 28
AMLODIPINE BESYLATE 208 180 11 7
GABAPENTIN 206 202 12 10
BENAZEPRIL HCL 195 185 13 97
FLUOXETINE HCL 195 181 13 44
LOSARTAN POTASSIUM 189 189 15 34
TRAMADOL HCL 185 184 16 13
PRAVASTATIN SODIUM 173 165 17 17
LISINOPRIL 160 130 18 2
CARVEDILOL 151 150 19 21
FAMOTIDINE 145 145 20 77
BENAZEPRIL-HYDROCHLOROTHIAZIDE 132 132 21 247
DOXYCYCLINE HYCLATE 127 123 22 113
CLOPIDOGREL 118 115 23 30
METFORMIN HCL 116 111 24 8
ALENDRONATE SODIUM 114 100 25 35
POLYETHYLENE GLYCOL 3350 113 111 26 45
ATORVASTATIN CALCIUM 112 88 27 15
SPIRONOLACTONE 110 87 28 83
CIPROFLOXACIN HCL 110 106 28 58
OXYBUTYNIN CHLORIDE ER 109 109 30 114
WARFARIN SODIUM 106 106 31 19
MELOXICAM 106 102 31 18
METFORMIN HCL ER 103 92 33 84
LOSARTAN-HYDROCHLOROTHIAZIDE 100 100 34 72
METOPROLOL SUCCINATE 98 94 35 20
ISOSORBIDE MONONITRATE ER 97 97 36 73
NAMENDA 97 96 36 31
FLUTICASONE PROPIONATE 95 93 38 27
NIFEDIPINE ER 91 91 39 185
SPIRIVA 85 85 40 53
CLONIDINE HCL 85 79 40 42
SERTRALINE HCL 84 83 42 24
ZETIA 81 54 43 109
DIGOXIN 81 69 43 47
AZITHROMYCIN 80 76 45 39
KLOR-CON 8 80 80 45 120
PLAVIX 78 75 47 49
ALLOPURINOL 77 77 48 36
ZOLPIDEM TARTRATE 75 75 49 16
PANTOPRAZOLE SODIUM 72 63 50 50
GLYBURIDE 72 72 R 50 59
AMIODARONE HCL 63 42 52 145
LOVASTATIN 61 61 53 41
BUSPIRONE HCL 56 54 54 96
ROPINIROLE HCL 56 56 54 68
PREDNISONE 55 54 56 48
CARBIDOPA-LEVODOPA 54 49 57 101
NEXIUM 53 40 58 26
FINASTERIDE 53 53 58 115
JANUVIA 52 52 60 75
ADVAIR DISKUS 51 48 61 43
FENTANYL 50 50 S2 62 65
METOPROLOL TARTRATE 50 49 62 12
QUETIAPINE FUMARATE 50 50 62 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.